HGF and neuroblastoma: Moreover, in vivo xenograft models of the inhibitor retarded tumor growth thereby implicating EMD1214063 as a promising therapeutic target for high-risk NB via its antagonistic effect on the HGF/c-Met activation (Scorsone et al., 2014).